BACKGROUND: In experimental models of human and mouse malaria, sterilizing liver stage immunity that blocks progression of Plasmodium infection to the symptomatic blood stage can be readily demonstrated. However, it remains unclear whether individuals in malaria-endemic areas acquire such immunity. METHODS: In Mali, 251 healthy children and adults aged 4-25 years who were free of blood-stage Plasmodium infection by polymerase chain reaction (PCR) were enrolled in a longitudinal study just prior to an intense 6-month malaria season. Subsequent clinical malaria episodes were detected by weekly active surveillance and self-referral. Asymptomatic P. falciparum infections were detected by blood-smear microscopy and PCR analysis of dried blood spots that had been collected every 2 weeks for 7 months. RESULTS: As expected, the risk of clinical malaria decreased with increasing age (log-rank test, P = .0038). However, analysis of PCR data showed no age-related differences in P. falciparum infection risk (log-rank test, P = .37). CONCLUSIONS: Despite years of exposure to intense P. falciparum transmission, there is no evidence of acquired, sterile immunity to P. falciparum infection in this population, even as clinical immunity to blood-stage malaria is clearly acquired. Understanding why repeated P. falciparum infections do not induce sterile protection may lead to insights for developing vaccines that target the liver stage in malaria-endemic populations.
BACKGROUND: In experimental models of human and mousemalaria, sterilizing liver stage immunity that blocks progression of Plasmodium infection to the symptomatic blood stage can be readily demonstrated. However, it remains unclear whether individuals in malaria-endemic areas acquire such immunity. METHODS: In Mali, 251 healthy children and adults aged 4-25 years who were free of blood-stage Plasmodium infection by polymerase chain reaction (PCR) were enrolled in a longitudinal study just prior to an intense 6-month malaria season. Subsequent clinical malaria episodes were detected by weekly active surveillance and self-referral. Asymptomatic P. falciparum infections were detected by blood-smear microscopy and PCR analysis of dried blood spots that had been collected every 2 weeks for 7 months. RESULTS: As expected, the risk of clinical malaria decreased with increasing age (log-rank test, P = .0038). However, analysis of PCR data showed no age-related differences in P. falciparum infection risk (log-rank test, P = .37). CONCLUSIONS: Despite years of exposure to intense P. falciparum transmission, there is no evidence of acquired, sterile immunity to P. falciparum infection in this population, even as clinical immunity to blood-stage malaria is clearly acquired. Understanding why repeated P. falciparum infections do not induce sterile protection may lead to insights for developing vaccines that target the liver stage in malaria-endemic populations.
Authors: G Snounou; S Viriyakosol; X P Zhu; W Jarra; L Pinheiro; V E do Rosario; S Thaithong; K N Brown Journal: Mol Biochem Parasitol Date: 1993-10 Impact factor: 1.759
Authors: Kathy A Mangold; Rebecca U Manson; Evelyn S C Koay; Lindsey Stephens; MaryAnn Regner; Richard B Thomson; Lance R Peterson; Karen L Kaul Journal: J Clin Microbiol Date: 2005-05 Impact factor: 5.948
Authors: Pascal Michon; Jennifer L Cole-Tobian; Elijah Dabod; Sonja Schoepflin; Jennifer Igu; Melinda Susapu; Nandao Tarongka; Peter A Zimmerman; John C Reeder; James G Beeson; Louis Schofield; Christopher L King; Ivo Mueller Journal: Am J Trop Med Hyg Date: 2007-06 Impact factor: 2.345
Authors: Peter D Crompton; Boubacar Traore; Kassoum Kayentao; Safiatou Doumbo; Aissata Ongoiba; Seidina A S Diakite; Michael A Krause; Didier Doumtabe; Younoussou Kone; Greta Weiss; Chiung-Yu Huang; Seydou Doumbia; Aldiouma Guindo; Rick M Fairhurst; Louis H Miller; Susan K Pierce; Ogobara K Doumbo Journal: J Infect Dis Date: 2008-11-01 Impact factor: 5.226
Authors: Arlene E Dent; Elke S Bergmann-Leitner; Danny W Wilson; Daniel J Tisch; Rhonda Kimmel; John Vulule; Peter Odada Sumba; James G Beeson; Evelina Angov; Ann M Moormann; James W Kazura Journal: PLoS One Date: 2008-10-29 Impact factor: 3.240
Authors: Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce Journal: Annu Rev Immunol Date: 2014 Impact factor: 28.527
Authors: Scott D Nash; D Rebecca Prevots; Edward Kabyemela; Yogender P Khasa; Kun-Lin Lee; Michal Fried; Patrick E Duffy Journal: Am J Trop Med Hyg Date: 2017-05 Impact factor: 2.345
Authors: Wesley C Van Voorhis; J Stone Doggett; Marilyn Parsons; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Michael W Riggs; Andrew Hemphill; Daniel K Howe; Robert H Mealey; Audrey O T Lau; Ethan A Merritt; Dustin J Maly; Erkang Fan; Kayode K Ojo Journal: Exp Parasitol Date: 2017-01-05 Impact factor: 2.011
Authors: Nyamekye Obeng-Adjei; Daniel B Larremore; Louise Turner; Aissata Ongoiba; Shanping Li; Safiatou Doumbo; Takele B Yazew; Kassoum Kayentao; Louis H Miller; Boubacar Traore; Susan K Pierce; Caroline O Buckee; Thomas Lavstsen; Peter D Crompton; Tuan M Tran Journal: JCI Insight Date: 2020-06-18
Authors: Isabel Rodriguez-Barraquer; Emmanuel Arinaitwe; Prasanna Jagannathan; Michelle J Boyle; Jordan Tappero; Mary Muhindo; Moses R Kamya; Grant Dorsey; Chris Drakeley; Isaac Ssewanyana; David L Smith; Bryan Greenhouse Journal: J Infect Dis Date: 2016-08-01 Impact factor: 5.226
Authors: William O Hahn; Noah S Butler; Scott E Lindner; Holly M Akilesh; D Noah Sather; Stefan Hi Kappe; Jessica A Hamerman; Michael Gale; W Conrad Liles; Marion Pepper Journal: JCI Insight Date: 2018-01-25